Join the High Cholesterol - Familial Homozygous group to help and get support from people like you.
High Cholesterol - Familial Homozygous News
Related terms: Familial Hypercholesterolemia, Homozygous, Homozygous Familial Hypercholesterolemia, Homozygous FH, Hypercholesterolemia, Familial Homozygous
Plozasiran Reduces Triglyceride Levels in Mixed Hyperlipidemia
MONDAY, June 3, 2024 – For individuals with mixed hyperlipidemia, plozasiran reduces triglyceride levels at 24 weeks, according to a study published online May 28 in the New England Journal of...
Statin Meds & Cholesterol: What You Need to Know
TUESDAY, March 5, 2024 – Statins have become the miracle medicine of modern heart care, lowering cholesterol levels and and guarding against heart attacks in millions of Americans. In fact, a...
Statin Meds & Cholesterol: What You Need to Know
TUESDAY, March 5, 2024 – Statins have become the miracle medicine of modern heart care, lowering cholesterol levels and and guarding against heart attacks in millions of Americans. In fact, a...
2015 to 2021 Saw Marked Rise in PCSK9 Inhibitor Utilization
TUESDAY, March 5, 2024 – Barriers for proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) use persist for cholesterol management, according to a research letter published online Feb. 16...
Watching Your Cholesterol? Virtual Doctor Visits Work Just as Well
THURSDAY, Dec. 7, 2023 – In a win for telemedicine, new research shows that folks fighting high cholesterol benefit just as much from online coaching as they do from in-person visits with a...
Statin Use Increased From 1999-2000 to 2013-2014, Then Plateaued
MONDAY, Dec. 4, 2023 – Overall statin use for primary prevention increased since 1999 to 2000 but has plateaued since 2013 to 2014, according to a research letter published online Dec. 5 in the...
Lipid-Lowering Drugs Save Lives, but Use Decreasing
FRIDAY, Dec. 1, 2023 – Lipid-lowering drugs for primary prevention are associated with a significant survival benefit, but use has decreased over time, according to a study published online Nov. 16...
FDA Approves First-in-class Evkeeza (evinacumab-dgnb) for Young Children with Ultra-Rare Form of High Cholesterol
TARRYTOWN, N.Y., March 22, 2023 (GLOBE NEWSWIRE) – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has extended the approval of Evkeeza...
FDA Medwatch Alert: FDA Requests Removal of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy; Still Advises Most Pregnant Patients Should Stop Taking Statins
What safety information is FDA announcing? The U.S. Food and Drug Administration (FDA) is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant...
FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia
Morristown, N.J. March 31, 2021 – Althera Pharmaceuticals, a company focused on heart health, today announced the FDA approval of Roszet (rosuvastatin and ezetimibe) tablets, as an adjunct to diet,...
FDA Approves Evkeeza (evinacumab-dgnb) for Patients with Homozygous Familial Hypercholesterolemia
TARRYTOWN, N.Y., Feb. 11, 2021 /PRNewswire/ – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) approved Evkeeza (evinacumab-dgnb) as an...
FDA Approves Amgen's Repatha (evolocumab) to Prevent Heart Attack and Stroke
THOUSAND OAKS, Calif., Dec. 1, 2017 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug...
FDA Approves Repatha (evolocumab) to Treat Certain Patients with High Cholesterol
August 27, 2015 – The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under...
FDA Approves Merck’s Liptruzet (ezetimibe and atorvastatin), a New Product That Can Help Lower LDL Cholesterol
Friday, May 3, 2013 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Liptruzet (ezetimibe and atorvastatin)...
FDA Approves New Orphan Drug Kynamro to Treat Inherited Cholesterol Disorder
January 29, 2013 – The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
atorvastatin, Lipitor, simvastatin, Repatha, Crestor, rosuvastatin